Resultados de la búsqueda 311-320 of 11105 for emerging infectious diseases
... disease progression, assess the need for treatment, and assess infection rates. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
Ear infections in children. National Institute on ... New York, N.Y.: The McGraw-Hill Companies; 2018. ... New York, N.Y.: The McGraw-Hill Companies; 2012.
... diseases. Data will contribute to creating ... Finding new surgical techniques can create better ... new Pathology/TRAG cryopreservation protocol ...
If there is a new change, a lump or something not typical in your breasts, report it to a healthcare professional right away. Breast awareness through self- ...
For various rare immunobullous diseases, detection of a circulating autoantibody is necessary for accurate diagnosis. ... new Pathology/TRAG cryopreservation ...
As new technologies develop, these cells may be able to be grown into new cells to replace those damaged by disease or injury. A Safety to Evaluate the ...
Reviews of Infectious Diseases (Revisiones de enfermedades infecciosas). ... The New England Journal of Medicine (Revista de Medicina de Nueva Inglaterra).
As new technologies develop, these cells may be able to be grown into new cells to replace those damaged by disease or injury. Numeración de páginas ...
To leverage deep learning models for classification, detection, and localization of tumor for extramammary Paget's disease on ex-vivo confocal microscopy images ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?